OpenVSafe by OpenVAERS
Search V-safe

EGX-23651-80440

5 vaccinations 5 coded responses 24 check-ins 5 free-text entries 1 call case
Sex
Male
Age at first dose
56-60
ZIP prefix
270 / NC
Registered
2020-12-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-21
    Registered in v-safe
  2. 2020-12-21
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-21
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-22
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good · Site: Pain
    Free text: No, feel normal
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-28
    Survey response — day 7, dose 1
    MedDRA: Pain — Feeling: Good
    Free text: Only symptom was mild soreness that only lasted 24 hours
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-01-04
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-01-08
    Dose 2 — Pfizer-BioNTech
  9. 2021-01-08
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  10. 2021-01-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest pain, Heart rate increased — Feeling: Fair · Site: Pain
    Free text: Increased heart rate since yesterday afternoon not associated with chest pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-10
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chills, Heart rate increased, Pain — Feeling: Good · Fever · Chills, Muscle or body aches · Be unable to do your normal daily activities
    Free text: Rapid heart rate 110-120bpm, the chills and aches happened yesterday after check-in. I feel fine today
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-10
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  13. 2021-01-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-01-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Nausea
    Adult check-in
  17. 2021-01-15
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-01-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-01-29
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-05
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-12
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-19
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-09
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-07-09
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-08-19
    Dose 3 — Pfizer-BioNTech
  26. 2022-01-08
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2022-02-05
    Dose 4 — Pfizer-BioNTech
  28. 2022-05-07
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  29. 2022-08-06
    Survey response — 6 months, dose 4
    MedDRA: Impaired work ability, Nasopharyngitis, SARS-CoV-2 test positive — Feeling: Good
    Free text: Had medium cold symptoms, no Covid specific symptoms such as headache, loss of smell/taste, nausea or loss of appetite. Tested positive for Covid with two home tests. Missed two days of work per CDC guidelines
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-09-26
    Dose 5 — Pfizer-BioNTech
  31. 2023-02-05
    Health check-in — 12 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-21Pfizer-BioNTech
22021-01-08Pfizer-BioNTech
32021-08-19Pfizer-BioNTech No
42022-02-05Pfizer-BioNTech No
52022-09-26Pfizer-BioNTech No

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-22

Systemic reaction (other): No, feel normal

Release 1 — day 7, dose 1

2020-12-28

Systemic reaction (other): Only symptom was mild soreness that only lasted 24 hours

Release 1 — days 1–6 daily, dose 2

2021-01-09

Systemic reaction (other): Increased heart rate since yesterday afternoon not associated with chest pain

2021-01-10

Systemic reaction (other): Rapid heart rate 110-120bpm, the chills and aches happened yesterday after check-in. I feel fine today

Release 12 — 6 months, dose 4

2022-08-06

Symptoms: Had medium cold symptoms, no Covid specific symptoms such as headache, loss of smell/taste, nausea or loss of appetite. Tested positive for Covid with two home tests. Missed two days of work per CDC guidelines

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDImpaired work ability · · ✓
SDNasopharyngitis · · ✓
SDSARS-CoV-2 test positive · · ✓
SROChest pain ✓ ✓ ✓
SROChills ✓ ✓ ✓
SROHeart rate increased ✓ ✓ ✓
SRONo adverse event ✓ ✓ ✓
SROPain ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release